Neurotech Investing & Partnering Conference Cancelled

In light of evolving updates and concerns around the coronavirus, we have made the difficult decision to cancel the Neurotech Investing & Partnering Conference.

Neurotech has always been a great opportunity to bring the neurotechnology and neuroscience ecosystems together, and advance the field. We are so disappointed to have to make this call, but feel it is the best way to move forward. We thank all of our stakeholders for their support in these uncertain times, and hope to work with all of you again in the future.

COVID-19 Updates and FAQ

Welcome to the Neurotech Investing & Partnering Conference

Now in its 15th year, the Neurotech Investing & Partnering Conference is the premier business investment conference for commercial neuroscience including pharmaceuticals, medical devices, diagnostics and neurosoftware. The conference features keynotes, investor panels, cutting edge company presentations on a comprehensive selection of neurotech topics. Our goal is to provide a highly-interactive environment where cutting edge technologies, devices, drugs and therapies inspire new collaborations and secure financing to navigate the development path and ultimately reach patients.


Collaborate and Meet with VC and Investors from:

Neurotech Attendee Audience Demographics

Partnering Opportunities from Across Commercial Neuroscience